C
Niagen Bioscience, Inc. NAGE
$6.88 -$0.07-1.01% NASDAQ
Recommendation
Prev Close
$7.54
Volume
2,011,418
Avg Vol (90D)
1,122,425
Market Cap
$602.60M
Dividend & Yield
--
52-Week Range
$3.83 - $14.69
P/E (TTM)
36.53
EPS (TTM)
$0.21
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Niagen Bioscience (NAGE) Profitability Shift Reinforces Bullish Value Narrative
11/6/2025 - Simply Wall St
Niagen Bioscience (NASDAQ:NAGE) Issues Earnings Results
11/6/2025 - MarketBeat
Niagen Bioscience price target lowered by $2 at Canaccord, here's why
11/5/2025 - The Fly
Niagen Bioscience (NAGE, $6.95) entered Downtrend as Momentum indicator drops below 0 level on Nov 04, 2025
11/5/2025 - Tickeron - Stocks
Niagen Bioscience, Inc. 2025 Q3 - Results - Earnings Call Presentation
11/5/2025 - SeekingAlpha
Niagen Bioscience Inc (NAGE) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...
11/5/2025 - GuruFocus
Niagen Bioscience Reports Strong Q3 2025 Results
11/5/2025 - TipRanks Financial Blog
Q3 2025 Niagen Bioscience Inc Earnings Call Transcript
11/5/2025 - GuruFocus
Niagen Bioscience raises revenue growth outlook to 25%-30% for 2025 while expanding clinic and telehealth reach
11/4/2025 - SeekingAlpha.com: All News
Niagen Bioscience, Inc. (NAGE) Q3 2025 Earnings Call Transcript
11/4/2025 - Seeking Alpha: Transcripts
Niagen Bioscience, Inc. (NAGE) Q3 2025 Earnings Call Transcript
11/4/2025 - SeekingAlpha
Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates
11/4/2025 - Zacks Investment Research
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased ...
11/4/2025 - GuruFocus
NAGE: Strong Q3 Performance Boosts Niagen Bioscience's Growth
11/4/2025 - GuruFocus
Niagen Bioscience Inc (NAGE) Q3 2025 Earnings: EPS of $0. ...
11/4/2025 - GuruFocus
A Fresh Look at Niagen Bioscience (NAGE) Valuation Ahead of Q3 2025 Earnings Release
11/4/2025 - Simply Wall St
Niagen Bioscience reports Q3 EPS 5c vs 2c last year
11/4/2025 - TipRanks Financial Blog
Niagen Bioscience reiterates FY25 net sales growth view of 25%-30%
11/4/2025 - TipRanks Financial Blog
Niagen Bioscience reiterates FY25 net sales growth view of 25%-30%
11/4/2025 - The Fly
Niagen Bioscience reports Q3 EPS 5c vs 2c last year
11/4/2025 - The Fly
Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook
11/4/2025 - Business Wire
Niagen Bioscience Q3 2025 Earnings Preview
11/3/2025 - Seeking Alpha - Healthcare
Earnings To Watch: Niagen Bioscience Inc (NAGE) Reports Q3 2025 Result
11/3/2025 - GuruFocus
Niagen Bioscience (NAGE, $7.11) Stochastic Oscillator left the oversold zone on October 30, 2025
10/31/2025 - Tickeron - Stocks
Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline
10/29/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$116.30M
EBITDA (TTM)
$17.45M
EBIT (TTM)
$16.67M
Net Income (TTM)
$17.73M
Balance Sheet
Total Assets (Q)
$91.53M
Total Debt (Q)
$3.29M
Total Liabilities (Q)
$27.33M
Book Value Per Share (Q)
$0.8049
Cash Flow
Cash from Operations (TTM)
$21.21M
Cash from Investing (TTM)
-$257.00K
Cash from Financing (TTM)
$11.64M
Net Change in Cash (TTM)
$32.59M
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
1.60
7-Day Total Return
-7.28%
30-Day Total Return
-32.81%
60-Day Total Return
-29.29%
90-Day Total Return
-50.22%
Year to Date Total Return
25.55%
1-Year Total Return
17.41%
2-Year Total Return
417.29%
3-Year Total Return
319.51%
5-Year Total Return
54.95%
52-week Low
Nov 01, 2024 - $3.83
52-week High
Jun 30, 2025 - $14.69
Valuation
Market Cap
$602.60M - Small Cap
Enterprise Value
$545.57M
Price/Sales (TTM)
5.59
Price/Book (Q)
9.37
Dividends and Shares
Shares Outstanding
86.24
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.niagenbioscience.com
Phone Number
310 388 6706
Address
10900 Wilshire Blvd
Los Angeles, CA 90024
Country
United States
Year Founded
1999
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical... more
NASDAQ 11/05/2025 4:00PM Eastern Quotes delayed